Shiga, Japan

Shinobu Kobayashi

This inventor holds 2 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 1998-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinobu Kobayashi. Retrieved from https://idiyas.com/inventor/shinobu-kobayashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Shinobu Kobayashi

Introduction

Shinobu Kobayashi is a notable inventor based in Shiga, Japan. He has made significant contributions to the field of antibiotics, particularly through his work with Pseudomonas species. With a total of 2 patents, Kobayashi has established himself as a key figure in pharmaceutical innovation.

Latest Patents

His latest patents include "Micacocidin derivatives - Antibiotic produced by Pseudomonas sp. and process for the preparation." This work highlights his commitment to developing new antibiotic solutions that can combat resistant bacterial strains.

Career Highlights

Kobayashi is currently employed at Shionogi Company Limited, a prominent pharmaceutical company known for its research and development in innovative medicines. His role at Shionogi allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Kobayashi has worked alongside talented colleagues such as Shigetada Hidaka and Yoshio Hayase. These collaborations have further enhanced his research capabilities and have led to advancements in antibiotic development.

Conclusion

Shinobu Kobayashi's work in antibiotic innovation is commendable and reflects his dedication to improving healthcare. His contributions are vital in the ongoing battle against antibiotic resistance, and his patents will likely influence future research in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…